Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance

One nutritional challenge in critically ill patients is enteral feeding intolerance (EFI), but current prokinetic agents have uncertain efficacy and safety profiles. We conducted a longitudinal, single-center, retrospective study to evaluate the efficacy and safety of domperidone administered via th...

Full description

Bibliographic Details
Main Authors: Yisong Cheng, Chaoyue Chen, Hao Yang, Min Fu, Xi Zhong, Bo Wang, Zhi Hu, Min He, Zhongwei Zhang, Xiaodong Jin, Yan Kang, Qin Wu
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/11/9/846
id doaj-2afe823fda174e72b055329f7ec9d3d1
record_format Article
spelling doaj-2afe823fda174e72b055329f7ec9d3d12021-09-26T00:31:50ZengMDPI AGJournal of Personalized Medicine2075-44262021-08-011184684610.3390/jpm11090846Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding IntoleranceYisong Cheng0Chaoyue Chen1Hao Yang2Min Fu3Xi Zhong4Bo Wang5Zhi Hu6Min He7Zhongwei Zhang8Xiaodong Jin9Yan Kang10Qin Wu11Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Neurosurgery, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaOne nutritional challenge in critically ill patients is enteral feeding intolerance (EFI), but current prokinetic agents have uncertain efficacy and safety profiles. We conducted a longitudinal, single-center, retrospective study to evaluate the efficacy and safety of domperidone administered via the feeding tube versus intravenous (IV) metoclopramide among adult patients with EFI. The primary outcome was feeding success, defined as the proportion of patients with average percentage of daily protein prescription >80% of the target dose. The secondary outcomes were safety endpoints. Among 28,814 intensive care unit (ICU) admissions, 552 patients with EFI were included, 38 receiving IV metoclopramide and 514 receiving tube feeding domperidone. The proportion of feeding success in patients receiving tube feeding domperidone and IV metoclopramide was 42.02% and 21.05%, respectively. After 1:2 matching (IV metoclopramide to tube feeding domperidone), the proportion of feeding success was 40.79% in patients receiving tube feeding domperidone. Basically, after matching, there were no differences in any safety endpoints (mortality and length of stay during ICU and hospitalization, organ-support-treatment free days) or adverse events (recurrence of EFI, electrolyte disturbance, abdominal and other symptoms) between the two groups (<i>p</i> > 0.05). A logistic regression analysis in the matched cohort indicated that domperidone administered via the feeding tube was independently associated with feeding success. We found that tube feeding domperidone was efficient in increasing enteral nutrition delivery performance among critically ill adult patients with EFI.https://www.mdpi.com/2075-4426/11/9/846enteral nutritiondomperidonemetoclopramidefeeding successefficacysafety
collection DOAJ
language English
format Article
sources DOAJ
author Yisong Cheng
Chaoyue Chen
Hao Yang
Min Fu
Xi Zhong
Bo Wang
Zhi Hu
Min He
Zhongwei Zhang
Xiaodong Jin
Yan Kang
Qin Wu
spellingShingle Yisong Cheng
Chaoyue Chen
Hao Yang
Min Fu
Xi Zhong
Bo Wang
Zhi Hu
Min He
Zhongwei Zhang
Xiaodong Jin
Yan Kang
Qin Wu
Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance
Journal of Personalized Medicine
enteral nutrition
domperidone
metoclopramide
feeding success
efficacy
safety
author_facet Yisong Cheng
Chaoyue Chen
Hao Yang
Min Fu
Xi Zhong
Bo Wang
Zhi Hu
Min He
Zhongwei Zhang
Xiaodong Jin
Yan Kang
Qin Wu
author_sort Yisong Cheng
title Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance
title_short Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance
title_full Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance
title_fullStr Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance
title_full_unstemmed Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance
title_sort association between domperidone administered via feeding tube and feeding success in critically ill patients with enteral feeding intolerance
publisher MDPI AG
series Journal of Personalized Medicine
issn 2075-4426
publishDate 2021-08-01
description One nutritional challenge in critically ill patients is enteral feeding intolerance (EFI), but current prokinetic agents have uncertain efficacy and safety profiles. We conducted a longitudinal, single-center, retrospective study to evaluate the efficacy and safety of domperidone administered via the feeding tube versus intravenous (IV) metoclopramide among adult patients with EFI. The primary outcome was feeding success, defined as the proportion of patients with average percentage of daily protein prescription >80% of the target dose. The secondary outcomes were safety endpoints. Among 28,814 intensive care unit (ICU) admissions, 552 patients with EFI were included, 38 receiving IV metoclopramide and 514 receiving tube feeding domperidone. The proportion of feeding success in patients receiving tube feeding domperidone and IV metoclopramide was 42.02% and 21.05%, respectively. After 1:2 matching (IV metoclopramide to tube feeding domperidone), the proportion of feeding success was 40.79% in patients receiving tube feeding domperidone. Basically, after matching, there were no differences in any safety endpoints (mortality and length of stay during ICU and hospitalization, organ-support-treatment free days) or adverse events (recurrence of EFI, electrolyte disturbance, abdominal and other symptoms) between the two groups (<i>p</i> > 0.05). A logistic regression analysis in the matched cohort indicated that domperidone administered via the feeding tube was independently associated with feeding success. We found that tube feeding domperidone was efficient in increasing enteral nutrition delivery performance among critically ill adult patients with EFI.
topic enteral nutrition
domperidone
metoclopramide
feeding success
efficacy
safety
url https://www.mdpi.com/2075-4426/11/9/846
work_keys_str_mv AT yisongcheng associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance
AT chaoyuechen associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance
AT haoyang associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance
AT minfu associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance
AT xizhong associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance
AT bowang associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance
AT zhihu associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance
AT minhe associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance
AT zhongweizhang associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance
AT xiaodongjin associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance
AT yankang associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance
AT qinwu associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance
_version_ 1717365863993049088